November 28, 2022 by Chain Drug Review
AllianceRx Walgreens Pharmacy
Leading Headlines, Pharmacy
ORLANDO – In keeping with its purpose of providing hope and care for better tomorrows, AllianceRx Walgreens Pharmacy recently launched AllianceCares, the specialty and home delivery pharmacy’s new corporate giving program. As part of Giving Tuesday on Nov. 29, team members designated St. Jude Children’s Research Hospital as the first recipient of proceeds from the program’s semi-annual giving campaign. Tuck Tucker,
October 4, 2022 by Chain Drug Review
AllianceRx Walgreens Pharmacy
Leading Headlines, Pharmacy
ORLANDO – AllianceRx Walgreens Pharmacy has achieved reaccreditation through the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services. Accreditation is a process through which health care organizations demonstrate compliance with national standards. Accreditation by ACHC reflects an organization’s dedication and commitment to meeting standards that facilitate a higher level of performance and patient care. Jodi Sibell, director of accreditation
September 27, 2022 by Chain Drug Review
AllianceRx Walgreens Pharmacy, Phospholine Iodide
Leading Headlines, Pharmacy
ORLANDO, Fla. — AllianceRx Walgreens Pharmacy has received exclusive access to Phospholine Iodide (echothiophate iodide for ophthalmic solution) from Fera Pharmaceuticals. Phospholine Iodide is used to help reduce elevated intraocular pressure of glaucoma and for accommodative esotropia (the inward turning of the eye) in children. “AllianceRx Walgreens Pharmacy is excited to be able to offer
September 22, 2022 by Chain Drug Review
AllianceRx Walgreens Pharmacy
Leading Headlines, Pharmacy
ORLANDO – Ever committed to helping reduce overall pharmacy spend for patients and partners, AllianceRx Walgreens Pharmacy regularly performs clinical audits on its specialty claims. In 2021, the company realized $6.2 million in annualized savings through its dose optimization program, leading to an average savings of $6,173 per optimized dispense. Specialty drugs now account for 50% or greater
August 29, 2022 by Chain Drug Review
AllianceRx Walgreens Pharmacy
Pharmacy
ORLANDO — AllianceRx Walgreens Pharmacy is one of two specialty pharmacies Nobelpharma America, LLC, has selected to distribute its rare disease drug HYFTOR (sirolimus topical gel) 0.2%. HYFTOR treats facial angiofibroma (commonly presenting as small, red or pink bumps on the face) in adults and pediatric patients with tuberous sclerosis complex (TSC) 6 years and older.
June 24, 2022 by Chain Drug Review
AllianceRx Walgreens Pharmacy
Leading Headlines, Pharmacy
ORLANDO, Fla. — One of the country’s largest specialty and home delivery pharmacies is now AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of the company in January, necessitating the name change. “AllianceRx Walgreens Pharmacy is the same specialty and home delivery pharmacy our patients have come to trust and depend on for life-saving medications,”
April 6, 2022 by Chain Drug Review
AllianceRx Walgreens Pharmacy, AllianceRx Walgreens Prime
Leading Headlines, Pharmacy
ORLANDO, Fla. – AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand. Effective June 24, 2022, AllianceRx Walgreens Prime will become AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of AllianceRx Walgreens Prime in January, necessitating the name change. “While our name is changing, we
